Robert Snijder
Astellas Pharma (Japan)(JP)Astellas Pharma (Netherlands)(NL)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Pain Mechanisms and Treatments, Ion Channels and Receptors, Prostate Cancer Diagnosis and Treatment, Urinary Bladder and Prostate Research
Most-Cited Works
- → Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study(2016)160 cited
- → Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study(2016)102 cited
- → A proof‐of‐concept study: Mirabegron, a new therapy for overactive bladder(2013)96 cited
- → Introducing PIONEER: a project to harness big data in prostate cancer research(2020)39 cited
- → Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the ‘burden of therapy’ method(2021)30 cited
- → Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder(2017)24 cited
- → Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies(2017)24 cited
- → Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies(2019)23 cited
- → Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset(2019)21 cited
- → Diagnosis Patterns of CKD and Anemia in the Japanese Population(2020)19 cited